People with high levels of body fat stored in their belly or arms may be more likely to develop diseases like Alzheimer’s and Parkinson’s than people with low levels of fat in these areas, according to a study published in the July 24, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Investigadores de Mayo Clinic han establecido nuevos criterios para un síndrome de pérdida de memoria en las personas mayores que afecta específicamente al sistema límbico del cerebro. A menudo, este síndrome se puede confundir con la enfermedad de Alzheimer.
UCLA has been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in a new Medicare alternative payment model designed to support people living with dementia and their caregivers.
Cedars-Sinai programs serving older patients and people with dementia have earned esteemed national distinctions reserved for healthcare models that prioritize improved health and wellness among older adults—a rapidly growing segment of the U.S. population expected to nearly double in the coming decades.
Researchers at Washington University in St. Louis use microscopy to chart amyloid beta’s underlying structure and yield insight into neurodegenerative disease
In this episode, Dr. Stewart Graham discusses metabolomics in Alzheimer’s disease. He investigates how the disease affects the brain’s metabolism of small molecules such as lipids and amino acids.
Researchers at Mayo Clinic have established new criteria for a memory-loss syndrome in older adults that specifically impacts the brain's limbic system. It can often be mistaken for Alzheimer's disease.
Corewell Health is working with Johns Hopkins Bloomberg School of Public Health and North Carolina Agricultural and Technical State University to learn more about the multi-level risk and biopsychosocial factors that contribute to Alzheimer’s disease in Black Americans, leading to the development of effective, tailored behavioral and pharmacological interventions aimed at reducing the condition’s disparate attack.
A study conducted in four Latin American countries by researchers at Washington University School of Medicine in St. Louis reveals that racial disparities in brain health are due to social factors, with genetic ancestry playing no role.
Jung-Ah Lee, professor and associate dean for diversity, equity, inclusion and belonging at the University of California, Irvine’s Sue & Bill Gross School of Nursing, has been inducted into the International Nurse Researcher Hall of Fame by the Sigma Theta Tau International Honor Society of Nursing.
A new study looks at predicting how quickly people with early Alzheimer’s disease will experience cognitive decline. The study is published in the July 10, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. It also looked at how the new drugs recently approved for the disease may reduce decline.
The Mount Sinai Health System announced it had been selected by the Centers for Medicare & Medicaid Services (CMS) to participate in a new Medicare alternative payment model designed to support people living with dementia and their caregivers.
Advocate Health has been selected by the Centers for Medicare and Medicaid Services (CMS) to participate in the Guiding an Improved Dementia Experience (GUIDE) Model. Following years of neurocognitive disorders research pioneered by Advocate Health's academic core, Wake Forest University School of Medicine, patients across the health system’s footprint will now benefit from the GUIDE Model’s new standardized approach to care for patients with dementia and their caregivers.
Having higher levels of inflammation in your 20s and 30s may be linked to having memory and thinking problems at middle age, according to a study published in the July 3, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study looked at levels of C-reactive protein (CRP) in the blood.
An international team of researchers led by Penn Medicine will investigate the link between traumatic brain injuries (TBI) and Alzheimer’s disease and related dementias (ADRD) over the next five years with a $10 million grant from the National Institute of Neurological Disorders and Stroke (NINDS).
A workgroup convened by the Alzheimer's Association has published revised criteria for the diagnosis and staging of Alzheimer's disease that are based on the biology of the disease and reflect recent advancements in Alzheimer's research, diagnostics and treatment. The 2024 update includes an updated biomarker classification system that includes blood-based biomarkers (BBM) and a revised disease staging system.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
